Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Slaper-Cortenbach, I. C. M.
Right arrow Articles by Hoogerbrugge, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slaper-Cortenbach, I. C. M.
Right arrow Articles by Hoogerbrugge, P. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 1999; 38: 751-754
© 1999 British Society for Rheumatology


Paediatric Rheumatology: Autologous Stem Cell Transplantation in Rheumatic Diseases of Childhood

The depletion of T cells from haematopoietic stem cell transplants

Series Editor: P. Woo

I. C. M. Slaper-Cortenbach, M. J. G. J. Wijngaarden-du Bois, A. de Vries-van Rossen, H. P. E. Borst, H. van der Lelie1, H. G. van Heugten2, L. F. Verdonck2, N. M. Wulffraat3 and P. M. Hoogerbrugge4

CLB, Sanquin Blood Supply Foundation, Department of Transfusion Technology, Stem Cell Laboratory, Laboratory for Experimental and Clinical Immunology, Academic Medical Centre, University of Amsterdam,
1 Department of Internal Medicine, Academic Medical Centre, Amsterdam,
2 Department of Haematology, University Hospital Utrecht, Utrecht,
3 Department of Paediatric Immunology, University Hospital for Children, `het Wilhelmina Kinderziekenhuis', Utrecht and
4 Department of Paediatrics, University Hospital Leiden, Leiden,The Netherlands

Correspondence to: I. C. M. Slaper-Cortenbach, CLB Sanquin Blood Supply Foundation, Department of Transfusion Technology, Stem Cell Laboratory, PO Box 9190, 1006 AD Amsterdam, The Netherlands.

Abstract

Objective. In our laboratory, we have developed an immunorosette technique for the depletion of T cells from bone marrow transplants. Tetrameric complexes of monoclonal antibodies are able to form very stable immunorosettes, which are efficiently depleted with the aid of a blood cell separator. Major improvements over the original sheep red blood cell depletion are the use of human (patient or donor derived) erythrocytes instead of sheep-derived cells, and the possibility of using a closed system for separation in a cell separator. In contrast to bone marrow, mobilized haematopoietic stem cell transplants obtained after leucocytapheresis contain higher numbers of T cells. Therefore, a different approach is necessary.

Method. We have used two CD34 selection systems (IsolexTM 300SA and the ClinimacsTM) to perform T-cell depletions from peripheral blood stem cell (PBSC) transplants.

Results. Immunorosette T-cell depletion, with CD2/CD3 tetrameric complexes, of bone marrow transplants resulted in a mean 2.5 log depletion of T cells with a yield of 50% of the CD34+ cell population. Stem cell selection of PBSC transplants using one of the CD34 selection procedures resulted in a 4.5 log depletion of T cells for both systems, but with different results for the recovery of CD34+ cells. An increased yield of CD34+ cells was obtained with the ClinimacsTM procedure (57.9±9.0%) in comparison to the IsolexTM procedure (40.1±12.5%).

Conclusion. Our own immunorosette depletion technique and the two tested CD34 selection methods for stem cell transplants both resulted in a very efficient T-cell depletion with the recovery of 40–60% of the CD34+ haematopoietic stem cells present in the transplant.

KEY WORDS: T cells, Depletion, Haematopoietic stem cell transplants.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JCOHome page
H. M. Lokhorst, C. M. Segeren, L. F. Verdonck, B. van der Holt, R. Raymakers, M. H.J. van Oers, R. M.Y. Barge, H. C. Schouten, P. H.M. Westveer, M. M.C. Steijaert, et al.
Partially T-Cell-Depleted Allogeneic Stem-Cell Transplantation for First-Line Treatment of Multiple Myeloma: A Prospective Evaluation of Patients Treated in the Phase III Study HOVON 24 MM
J. Clin. Oncol., May 1, 2003; 21(9): 1728 - 1733.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
L R Wedderburn, M Abinun, P Palmer, and H E Foster
Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis
Arch. Dis. Child., March 1, 2003; 88(3): 201 - 205.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
L. R. Wedderburn, R. Jeffery, H. White, A. Patel, H. Varsani, D. Linch, K. Murray, and P. Woo
Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO+ to RA+ phenotype
Rheumatology, November 1, 2001; 40(11): 1299 - 1307.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.